Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_assertion type Assertion NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_head.
- NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_assertion description "[This includes the discovery that the pathological changes in atypical FTLD with ubiquitinated inclusions, neuronal intermediate filament inclusion disease, and basophilic inclusion body disease are immunoreactive for the fused in sarcoma (FUS) protein, resulting in the creation of a new molecular subgroup (FTLD-FUS), and studies clarifying the functional consequences of pathogenic CHMP2B mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_provenance.
- NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_assertion evidence source_evidence_literature NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_provenance.
- NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_assertion SIO_000772 21603977 NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_provenance.
- NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_assertion wasDerivedFrom befree-20140225 NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_provenance.
- NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_assertion wasGeneratedBy ECO_0000203 NP474133.RACkXp7eTYnUhANBpifUD2zjfuxsIHefJuxORBoGwdJ0Y130_provenance.